Pediatricians at the Charit afrodisiakum?

Pediatricians at the Charit? University Hospital in Berlin, try to find out how far the death rate of viral infections, especially in leukemia patients after bone marrow or stem cell transplantation by the preventive use of cellular immunotherapy can be reduced afrodisiakum . Additional long-term Adoptive Immunotherapy for adenovirus-associated complications after transplantation, focuses on the the children and adolescents between the ages of 2 and 18 years. Total funding: Total funding: EUR957, 824 Coordinator. negative symptoms also affected by negative symptoms . , , Cognitive behavior therapy treatment of negative symptoms in patients with schizophrenia , the University of the University of T? Bingen should clarify whether cognitive behavior therapy is effective in the treatment of negative symptoms. This therapy has no side effects and can be a big step forward, especially negative symptoms remain often have healed after the positive symptoms. .

Mersana, a cancer therapeutics company, announced intermediate results of a Phase I trial with its lead product, XMT-1001, of patients with advanced solid tumors. The data were presented by Edward A. Sausville, Professor of Medicine and an Associate Director in clinical research, University of Maryland Greenebaum Cancer Center in a poster session on 23rd October 2007, at the AACR-NCI-EORTC International Symposium on Molecular Targets and Therapeutics in San Francisco, The complete text the abstract# A146 A phase I study the safety, tolerability and pharmacokinetics to intravenous XMT – 1001 in Patients with advanced solid cancers can be viewed online presented at the AACR Web site XMT-1001 is a polymer based pro-drug camptothecin , a well-characterized topoisomerase I inhibitor having potent anti-tumor activity. – Commenting on the information, Robert J. MD Chief Medical Officer of at Mersana is said, The Stage I The results show that in humans, drug-related far we have the active compound in XMT 1001, from the from the carriers as Fleximer a prodrug to an extent may be be allocated avoid joint security problems with drugs in this class. So far we have no evidence for drug – related serious adverse events and that degree has views in progress. .